Amarillo Biosciences (AMAR) stock price, revenue, and financials

Amarillo Biosciences market cap is $6.3 m, and annual revenue was $77.72 k in FY 2018

$6.3 M

AMAR Mkt cap, 31-Oct-2017

$606

Amarillo Biosciences Revenue Q2, 2019
Amarillo Biosciences Gross profit (Q2, 2019)43
Amarillo Biosciences Gross profit margin (Q2, 2019), %7.1%
Amarillo Biosciences Net income (Q2, 2019)-453.5 K
Amarillo Biosciences EBIT (Q2, 2019)-455 K
Amarillo Biosciences Cash, 30-Jun-2019723.4 K

Amarillo Biosciences Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

250.9k77.7k

Cost of goods sold

60.3k64.9k

Gross profit

190.6k12.8k

Gross profit Margin, %

76%17%

R&D expense

133.0k133.0k32.6k

General and administrative expense

433.2k69.7k521.8k667.1k770.4k1.3m

Operating expense total

566.2k202.7k521.8k667.1k579.8k1.3m

EBIT

(566.2k)(69.7k)(519.8k)(667.1k)(579.8k)(1.3m)

EBIT margin, %

(231%)(1717%)

Interest expense

103.4k448.02.1k2.9k37.6k4.0k

Net Income

(622.6k)(70.2k)(521.9k)(670.0k)(617.4k)(1.3m)

Amarillo Biosciences Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

6.5k318.6k21.1k134.1k2.0m1.3m

Inventories

14.7k22.7k

Current Assets

68.5k335.4k39.3k262.4k2.1m1.3m

PP&E

5.8k44.2k27.0k14.0k

Total Assets

161.5k421.5k117.2k462.7k2.3m1.5m

Accounts Payable

288.2k67.2k58.6k165.5k159.3k115.3k

Current Liabilities

4.9m302.3k589.2k1.3m1.8m733.6k

Total Liabilities

4.9m589.2k1.3m1.8m733.6k

Common Stock

201.4k

Preferred Stock

33.0

Additional Paid-in Capital

32.0m(157.4k)(76.9k)237.5k2.1m3.5m

Retained Earnings

(37.5m)(74.7k)(596.6k)(1.3m)(1.9m)(3.2m)

Total Equity

(4.8m)(30.7k)(472.0k)(809.9k)470.8k730.1k

Financial Leverage

0 x-13.7 x-0.2 x-0.6 x4.9 x2 x

Amarillo Biosciences Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(622.6k)(70.2k)(521.9k)(670.0k)(617.4k)(1.3m)

Depreciation and Amortization

16.1k3.0k19.8k26.0k40.0k56.2k

Inventories

(14.7k)(8.0k)22.7k

Accounts Payable

(61.8k)6.3k(8.6k)107.0k(9.5k)54.8k

Cash From Operating Activities

(664.2k)(53.0k)(366.4k)(520.8k)(542.7k)(1.0m)

Cash From Investing Activities

(15.1k)(2.8k)(11.6k)(148.3k)(49.1k)(7.3k)

Cash From Financing Activities

678.6k877.6k80.6k782.1k2.4m255.0k

Interest Paid

4.1k63.0k910.01.3k29.3k3.8k

Free Cash Flow

(373.5k)(568.5k)(1.0m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Net Income

(102.8k)(114.1k)(121.6k)(136.2k)(179.3k)(189.0k)

Cash From Operating Activities

(474.9k)(110.7k)(183.7k)(260.3k)(207.4k)(89.1k)1.7k(325.1k)(427.0k)(126.5k)(216.2k)(539.1k)

Cash From Investing Activities

(14.1k)(19.0)(7.8k)(7.8k)(11.1k)(11.6k)(8.6k)(68.1k)(102.2k)(5.3k)(25.8k)(39.9k)(1.7k)(2.1k)55.6k(1.6k)(1.6k)

Cash From Financing Activities

490.8k108.0k186.5k261.9k261.9k250.0k684.4k684.4k50.6k120.6k239.4k(195.0k)(195.0k)(195.0k)(12.5k)(12.5k)

Interest Paid

3.7k1.3k792.01.1k3.8k69.0203.0

Income Taxes Paid

Amarillo Biosciences Ratios

USDY, 2019

Financial Leverage

3.9 x